Przezustna endoskopowa miotomia w leczeniu achalazji wpustu – opis przypadku

Achalasia is an uncommon primary motility disorder of the esophagus characterized by incomplete relaxation of the lower esophageal sphincter (LES) and loss of coordinated peristalsis in the esophageal body. Its pathogenesis is linked to inflammatory degeneration of inhibitory myenteric neurons that normally release nitric oxide and vasoactive intestinal peptide. The condition affects both sexes and occurs most often between 25 and 60 years of age, with incidence rising steadily in later decades. Achalasia accounts for approximately 70% of primary esophageal motility disorders, with an annual incidence of about 1.6 cases per 100 000 population. The median diagnostic delay is 4.7 years. Hallmark clinical features include progressive dysphagia to both solids and liquids, chest pain, regurgitation of undigested food or saliva, and unintended weight loss. Early recognition and timely intervention are essential to prevent long-term complications and to improve quality of life.

Authors

Institutions

Publication Details

Journal
Medical Forum.
Published
2025-01-01
DOI
https://doi.org/10.15804/mf.2025101
Primary Topic
Esophageal and GI Pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Przezustna endoskopowa miotomia w leczeniu achalazji wpustu – opis przypadku

Mateusz Jagielski, Jacek Drzewiecki, Bartłomiej Zaranek
Medical Forum.
Esophageal and GI Pathology
article

Przezustna endoskopowa miotomia w leczeniu achalazji wpustu – opis przypadku

Mateusz Jagielski, Jacek Drzewiecki, Bartłomiej Zaranek
article en

Abstract

Achalasia is an uncommon primary motility disorder of the esophagus characterized by incomplete relaxation of the lower esophageal sphincter (LES) and loss of coordinated peristalsis in the esophageal body. Its pathogenesis is linked to inflammatory degeneration of inhibitory myenteric neurons that normally release nitric oxide and vasoactive intestinal peptide. The condition affects both sexes and occurs most often between 25 and 60 years of age, with incidence rising steadily in later decades. Achalasia accounts for approximately 70% of primary esophageal motility disorders, with an annual incidence of about 1.6 cases per 100 000 population. The median diagnostic delay is 4.7 years. Hallmark clinical features include progressive dysphagia to both solids and liquids, chest pain, regurgitation of undigested food or saliva, and unintended weight loss. Early recognition and timely intervention are essential to prevent long-term complications and to improve quality of life.

Medical Forum.Vol. Vol. 3(Issue 1)
Wojewódzki Szpital Zespolony (PL), Collegium Medicum in Bydgoszcz (PL)
Openalex Percentile: Top 57%
Esophageal and GI Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.